Skip to content

AnaptysBio, Inc. ANAB Total Current Assets

Total Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$27.21B-11.6%
Eli Lilly logo
Eli LillyLLY
$54.84B+32.9%
Pfizer logo
PfizerPFE
$42.82B-6.6%
Amgen logo
AmgenAMGN
$31.48B+16.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$18.21B+3.6%
Biogen logo
BiogenBIIB
$9.19B+20.5%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.73B+180%
Enterprise value$1.48B+176%
P/S7.4×+1.9×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s total current assets?
AnaptysBio, Inc. (ANAB) reported total current assets of $316.11M in Q1 2026.
How has AnaptysBio, Inc.'s total current assets changed year-over-year?
AnaptysBio, Inc.'s total current assets decreased by 12.9% year-over-year, from $363.11M to $316.11M.
What is the long-term trend for AnaptysBio, Inc.'s total current assets?
Over 5 years (2020 to 2025), AnaptysBio, Inc.'s total current assets has grown at a -2.5% compound annual growth rate (CAGR), from $396.56M to $350.25M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.